172@29@17@240!~!172@29@0@53!~!|news|business|stocks|cipla-to-acquire-us-inhaler-maker-for-rs-1000-crore-5884681.html!~!news|moneycontrol|com!~!|controller|infinite_scroll_article.php!~!is_mobile=false
Moneycontrol
FREE virtual training session on Passive Income Secrets: October 24 and 25, 2020, 10am to 1pm. Register Now!
Last Updated : Sep 25, 2020 03:38 PM IST | Source: Moneycontrol.com

Cipla to acquire US inhaler-maker for Rs 1,000 crore

The acquisition will help Cipla to boost manufacturing capabilities in the US along with getting some ANDA pipeline in the future.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Yatin Mota – CNBC AWAAZ

Pharma Major Cipla is all set to announce an acquisition shortly in the US market, two sources familiar with the development on the condition of anonymity told CNBC Awaaz.

Cipla according to sources is said to have completed due diligence of a company specialising in respiratory and inhaler portfolio.

Close

The acquisition is also said to boost Cipla's business in the US especially a segment which caters to the US government orders in COVID times.

"Cipla has completed due diligence of a company in US and the acquisition size could be Rs 700-1,000 crore in value. Cipla is most likely to close the deal in a months’ time," said one of the sources mentioned above.

The acquisition will help Cipla to boost manufacturing capabilities in the US along with getting some ANDA pipeline in the future.

Cipla is looking to focus on the US Markets with increased drug approval pipeline and inorganic growth opportunities especially having manufacturing facilities in the US.
First Published on Sep 25, 2020 03:38 pm

tags #Cipla

Sections